In addition, chronic inflammation, being an important pathogenic mechanism in the development of obesity and associated conditions, may sustain the activated state of FAP, thus contributing to the development and progression of the so-called fibrofatty degeneration of skeletal muscles in obesity. This evidence concerns the gene FAP and obesity due to melanocortin 4 receptor deficiency.